These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11052952

  • 1. Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women.
    Lange KH, Isaksson F, Juul A, Rasmussen MH, Bülow J, Kjaer M.
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E989-96. PubMed ID: 11052952
    [Abstract] [Full Text] [Related]

  • 2. Endurance training and GH administration in elderly women: effects on abdominal adipose tissue lipolysis.
    Lange KH, Lorentsen J, Isaksson F, Juul A, Rasmussen MH, Christensen NJ, Bülow J, Kjaer M.
    Am J Physiol Endocrinol Metab; 2001 Jun; 280(6):E886-97. PubMed ID: 11350770
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.
    JAMA; 2002 Nov 13; 288(18):2282-92. PubMed ID: 12425705
    [Abstract] [Full Text] [Related]

  • 5. GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake.
    Lange KH, Isaksson F, Rasmussen MH, Juul A, Bülow J, Kjaer M.
    Clin Endocrinol (Oxf); 2001 Jul 13; 55(1):77-86. PubMed ID: 11453955
    [Abstract] [Full Text] [Related]

  • 6. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB.
    Clin Nephrol; 2000 Feb 13; 53(2):99-107. PubMed ID: 10711411
    [Abstract] [Full Text] [Related]

  • 7. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.
    Giannoulis MG, Sonksen PH, Umpleby M, Breen L, Pentecost C, Whyte M, McMillan CV, Bradley C, Martin FC.
    J Clin Endocrinol Metab; 2006 Feb 13; 91(2):477-84. PubMed ID: 16332938
    [Abstract] [Full Text] [Related]

  • 8. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May 13; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 9. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
    Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R.
    J Clin Endocrinol Metab; 1994 Nov 13; 79(5):1361-6. PubMed ID: 7525633
    [Abstract] [Full Text] [Related]

  • 10. Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults.
    Woodhouse LJ, Asa SL, Thomas SG, Ezzat S.
    J Clin Endocrinol Metab; 1999 Dec 13; 84(12):4570-7. PubMed ID: 10599721
    [Abstract] [Full Text] [Related]

  • 11. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.
    J Clin Endocrinol Metab; 2005 Aug 13; 90(8):4474-82. PubMed ID: 15914526
    [Abstract] [Full Text] [Related]

  • 12. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.
    Berggren A, Ehrnborg C, Rosén T, Ellegård L, Bengtsson BA, Caidahl K.
    J Clin Endocrinol Metab; 2005 Jun 13; 90(6):3268-73. PubMed ID: 15784718
    [Abstract] [Full Text] [Related]

  • 13. Endurance but not resistance training increases intra-myocellular lipid content and β-hydroxyacyl coenzyme A dehydrogenase activity in active elderly men.
    Ngo KT, Denis C, Saafi MA, Feasson L, Verney J.
    Acta Physiol (Oxf); 2012 May 13; 205(1):133-44. PubMed ID: 22017921
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
    Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L.
    J Clin Endocrinol Metab; 2003 Apr 13; 88(4):1455-63. PubMed ID: 12679422
    [Abstract] [Full Text] [Related]

  • 15. Glucose flux is normalized by compensatory hyperinsulinaemia in growth hormone-induced insulin resistance in healthy subjects, while skeletal muscle protein synthesis remains unchanged.
    Nygren J, Thorell A, Brismar K, Essén P, Wernerman J, McNurlan MA, Garlick PJ, Ljungqvist O.
    Clin Sci (Lond); 2002 Apr 13; 102(4):457-64. PubMed ID: 11914108
    [Abstract] [Full Text] [Related]

  • 16. Whole-body fat oxidation determined by graded exercise and indirect calorimetry: a role for muscle oxidative capacity?
    Nordby P, Saltin B, Helge JW.
    Scand J Med Sci Sports; 2006 Jun 13; 16(3):209-14. PubMed ID: 16643200
    [Abstract] [Full Text] [Related]

  • 17. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J, Lönn L, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjöström L, Bengtsson BA.
    J Clin Endocrinol Metab; 1998 Feb 13; 83(2):362-9. PubMed ID: 9467542
    [Abstract] [Full Text] [Related]

  • 18. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M, Scacchi M, Pincelli AI, Berselli ME, Silvestri P, Montesano A, Ortolani S, Dubini A, Cavagnini F.
    Int J Obes Relat Metab Disord; 1998 Sep 13; 22(9):836-41. PubMed ID: 9756240
    [Abstract] [Full Text] [Related]

  • 19. Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial.
    Christensen B, Nellemann B, Larsen MS, Thams L, Sieljacks P, Vestergaard PF, Bibby BM, Vissing K, Stødkilde-Jørgensen H, Pedersen SB, Møller N, Nielsen S, Jessen N, Jørgensen JO.
    Am J Physiol Endocrinol Metab; 2013 Oct 01; 305(7):E879-89. PubMed ID: 23921143
    [Abstract] [Full Text] [Related]

  • 20. The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men.
    Harman SM, Blackman MR.
    Horm Res; 2003 Oct 01; 60(Suppl 1):121-4. PubMed ID: 12955028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.